12 /100
LOW RISK
Score updated Apr 13, 2026

NAMS

NewAmsterdam Pharma Company N.V. — Stock Dilution Tracker

Track NAMS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

🔔 Track NAMS — Get alerts when the score changes →
📊 Score Breakdown
📋 Offering Ability
20
💰 Cash Runway
0
📊 Float Risk
20
⚠️ Warrant Exposure
15
🔄Convertible Debt
🌦️ Dilution Forecast
☀️
Clear
No significant dilution signals
0%
No significant dilution signals detected for NAMS.
🔔 Track NAMS — Get forecast alerts →
💹 Market Data
Market Cap$4.00B
Shares Outstanding114.98M
Float71.47M
Cash$636.24M
Debt$202.0K
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↓ 3.8% shares (2025Q4 vs prior)
185 institutional holders · 119.96M shares
#1 Frazier Life Sciences Management, L.P. 16.94M shares
#2 Capital World Investors 9.98M shares
#3 RA CAPITAL MANAGEMENT, L.P. 9.55M shares
+ 17 more holders Sign up free to view →
📉 Short Interest
Short Interest8.05M
Days to Cover9.6
% of Float11.3%
FINRA data as of Mar 31, 2026
📁 Recent SEC Activity
xbrl XBRL WARRANT Dec 31, 2025
xbrl XBRL CONVERTIBLE Dec 31, 2021
Full SEC filing analysis available with free account
📰 Recent News
Track NAMS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NAMS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required